Molecular targets for diagnostic and intraoperative imaging of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX treatment

Neoadjuvant systemic treatment is increasingly being integrated in the standard treatment of pancreatic ductal adenocarcinoma (PDAC) patients to improve oncological outcomes. Current available imaging techniques remain unreliable in assessing response to therapies, as they cannot distinguish between...

Descripción completa

Detalles Bibliográficos
Autores principales: Vuijk, F. A., de Muynck, L. D. A. N., Franken, L. C., Busch, O. R., Wilmink, J. W., Besselink, M. G., Bonsing, B. A., Bhairosingh, S. S., Kuppen, P. J. K., Mieog, J. S. D., Sier, C. F. M., Vahrmeijer, A. L., Verheij, J., Fariňa-Sarasqueta, A., Swijnenburg, R. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529886/
https://www.ncbi.nlm.nih.gov/pubmed/33004930
http://dx.doi.org/10.1038/s41598-020-73242-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529886/
https://www.ncbi.nlm.nih.gov/pubmed/33004930
http://dx.doi.org/10.1038/s41598-020-73242-6

Ejemplares similares